Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,595.00
Bid: 1,594.00
Ask: 1,594.50
Change: -13.50 (-0.84%)
Spread: 0.50 (0.031%)
Open: 1,604.50
High: 1,609.00
Low: 1,586.50
Prev. Close: 1,608.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Stocks fall as US inflation tops expectations

Tue, 13th Feb 2024 16:21

(Sharecast News) - London markets ended the trading day in negative territory on Tuesday, influenced by concerns over higher inflation figures from the United States and a deceleration in wage growth within the UK.

The FTSE 100 closed down 0.81% at 7,512.28 points, while the FTSE 250 fell 1.46% to settle at 18,923.83 points.

In currency markets, sterling was last down 0.21% on the dollar to trade at $1.2602, while it managed a modest uptick against the euro, gaining 0.33% to change hands at €1.1762.

"January consumer price inflation falling less than expected was enough of a catalyst to cut the equity rally short, push yields and the US dollar to two-month highs," said IG senior market analyst Axel Rudolph.

"Hopes for a Fed March rate cut have all but disappeared with the market now pricing in a 53% probability of a first cut being seen in June."

Rudolph said the Brent crude oil price was on track for its seventh straight day of gains, albeit at a slower pace, as investors mulled over the situation in the Middle East and supply concerns.

"US natural gas prices continue to slide, though, and hit their lowest level since July 2020 amid ample production levels and subdued demand due to more clement weather.

"The higher-than-expected US CPI reading provoked a sharp decline in the gold price with it now trading in two-month lows below the psychological $2,000 per troy ounce mark."

Unemployment rate decreases in UK, US inflation remains hot

In economic news, the Office for National Statistics reported that the unemployment rate for individuals aged 16 and over decreased to 3.8% in the three months to December, down from November's 4.2% and surpassing expectations for 4.0%.

However, the economic inactivity rate rose to 21.9%, primarily driven by the number of long-term sick individuals, which remained notably high.

Claimant counts for January increased by 14,100 on a monthly basis and 61,200 on a yearly basis, totalling 1.579 million.

Despite that, the employment rate stood at 75.0%.

Vacancies fell by 26,000 in the quarter, marking the 19th consecutive month of decline, although they still surpassed pre-pandemic levels.

Notably, wage growth exceeded forecasts, with average regular earnings for employees, excluding bonuses, rising by 6.2% annually, contrasting with predictions of 6.0%.

Including bonuses, wages grew by 5.8%.

Real-term annual growth for total pay was 1.4%, and 1.8% for regular pay.

However, the ONS expressed caution regarding labour force survey (LFS) estimates due to smaller sample sizes resulting from changes in methodology.

"Official data continue to suggest that the labour market remains tight, though their veracity remains questionable," said Samuel Tombs, chief UK economist at Pantheon Macroeconomics.

"The latest LFS estimates are based on the ONS' new population projections, but work to boost the response rate remains incomplete.

"Accordingly, the ONS says that the data should be treated with additional caution."

Tombs said the recent dip in the unemployment rate from its post-Covid peak of 4.3% in July looked "particularly suspect".

"Many surveys indicate that staff availability for vacancies has improved."

Meanwhile, inflation in the US surged beyond expectations in January, driven largely by increases in shelter prices.

According to the Bureau of Labor Statistics, the consumer price index rose by 3.1% year-on-year, exceeding the anticipated 2.9% increase and marking a continuation from December's 3.4% rise.

Core CPI, excluding food and energy prices, increased by 0.4% last month and stood at 3.9% higher annually, outpacing forecasts.

Notably, shelter prices, comprising a significant portion of the CPI, rose by 0.6% monthly, contributing substantially to the overall increase, while food prices also saw a 0.4% uptick.

However, energy prices declined by 0.9%, largely due to a 3.3% drop in gas prices.

Finally on data, there was a notable improvement in economic sentiment in Germany according to a closely-monitored survey.

The latest ZEW indicator of economic sentiment rose by 4.7 points in February, reaching 19.9, marking the seventh consecutive month of increase.

However, the indicator reflecting the current economic situation dropped by 4.4 points to -81.7, the lowest since June 2020, at the onset of the pandemic.

Housebuilders fall on jobs data, Aston Martin in the green

On London's equity markets, housebuilders and property-related firms were in focus, with Persimmon, Barratt Developments, Taylor Wimpey, and Rightmove all suffering losses of between 3.04% and 4.59%.

The downturn followed the release of the UK jobs data, which hinted at the potential for prolonged higher interest rates, thereby impacting sentiment in the property market.

Crest Nicholson, Redrow, Shaftesbury Capital, UK Commercial Property REIT, and Tritax EuroBox also registered declines in response to the aforementioned news, with Crest Nicholson tumbling 6.37%.

Travel firm TUI closed marginally lower despite reporting a positive quarterly underlying profit and affirming its full-year guidance.

The company's underlying earnings before interest and tax for the last quarter were €6 million, marking a significant milestone since the merger of TUI AG and TUI Travel plc in 2014.

Group revenues also saw a notable increase of 15% year-on-year, driven by improved demand and pricing.

On the upside, luxury car maker Aston Martin Lagonda increased 1.13%, attributed to statements from executive chairman Lawrence Stroll regarding efforts to address the company's significant debt.

Stroll confirmed ongoing discussions with bankers to tackle a looming debt pile, which currently stood at $1.4bn.

Pharmaceutical giant GSK managed gains of 0.95% rise following a broker upgrade from Citi, which shifted its rating from 'neutral' to 'buy'.

Citi cited promising data related to GSK's novel treatment for multiple myeloma, Blenrep, as well as other positive indicators.

The bank's upgraded earnings per share forecasts, reflecting peak Blenrep revenues of about £2.5bn, underscored the newfound confidence in GSK's prospects.

Reporting by Josh White for Sharecast.com.

Market Movers

FTSE 100 (UKX) 7,512.28 -0.81%

FTSE 250 (MCX) 18,923.83 -1.46%

techMARK (TASX) 4,340.39 -1.09%

FTSE 100 - Risers

AstraZeneca (AZN) 9,600.00p 1.04%

GSK (GSK) 1,641.80p 0.95%

Centrica (CNA) 135.55p 0.82%

HSBC Holdings (HSBA) 610.50p 0.35%

Anglo American (AAL) 1,756.00p 0.25%

BP (BP.) 479.75p 0.06%

Hikma Pharmaceuticals (HIK) 1,960.00p 0.03%

Severn Trent (SVT) 2,495.00p 0.00%

Unilever (ULVR) 3,992.50p -0.01%

Smith & Nephew (SN.) 1,096.50p -0.14%

FTSE 100 - Fallers

Barratt Developments (BDEV) 466.10p -4.59%

Taylor Wimpey (TW.) 141.15p -4.39%

Fresnillo (FRES) 471.80p -4.38%

Entain (ENT) 973.80p -4.25%

Persimmon (PSN) 1,361.50p -4.05%

Airtel Africa (AAF) 98.70p -3.89%

Scottish Mortgage Inv Trust (SMT) 779.60p -3.45%

Berkeley Group Holdings (The) (BKG) 4,577.00p -3.44%

RS Group (RS1) 765.00p -3.21%

Ocado Group (OCDO) 519.60p -3.20%

FTSE 250 - Risers

Plus500 Ltd (DI) (PLUS) 1,822.00p 1.62%

Auction Technology Group (ATG) 564.00p 1.44%

SDCL Energy Efficiency Income Trust (SEIT) 57.00p 1.24%

PPHE Hotel Group Ltd (PPH) 1,230.00p 1.23%

easyJet (EZJ) 553.40p 1.21%

JPMorgan Japanese Inv Trust (JFJ) 511.00p 0.99%

Diversified Energy Company (DEC) 915.50p 0.88%

Trustpilot Group (TRST) 185.70p 0.70%

Baltic Classifieds Group (BCG) 229.50p 0.66%

Balanced Commercial Property Trust Limited (BCPT) 78.50p 0.64%

FTSE 250 - Fallers

Crest Nicholson Holdings (CRST) 211.60p -6.37%

UK Commercial Property Reit Limited (UKCM) 63.60p -5.50%

Close Brothers Group (CBG) 402.20p -5.45%

Tritax Eurobox (GBP) (EBOX) 47.60p -4.80%

Great Portland Estates (GPE) 366.60p -4.68%

Mobico Group (MCG) 79.25p -4.58%

Redrow (RDW) 654.00p -4.55%

Bridgepoint Group (Reg S) (BPT) 264.60p -4.20%

IWG (IWG) 190.60p -4.12%

Abrdn (ABDN) 158.90p -3.90%

More News
Today 08:25

Merck KGaA shares plunge after cancer drug hopeful fails

FRANKFURT, June 25 (Reuters) - Shares in Germany's Merck KGaA slumped 8.9% at the open on Tuesday after the diversified group late on Monday said a trial testing a head and neck cancer drug, previously seen as promising, would be stopped for lack of efficacy.

Read more
24 Jun 2024 08:55

TOP NEWS: GSK hails Omjjara approval in Japan; Jemperli review in EU

(Alliance News) - GSK PLC on Monday said it has landed an approval in Japan and also highlighted regulatory progress in the EU.

Read more
24 Jun 2024 07:43

LONDON BRIEFING: Prudential announces buyback; Frasers and THG in deal

(Alliance News) - London's FTSE 100 is called to open lower at the start of the week, with share price falls for major US tech shares, Nvidia included, spooking investors on this side of the Atlantic.

Read more
24 Jun 2024 07:21

GSK reports regulatory progress for Omjjara, Jemperli

(Sharecast News) - GSK announced on Monday that it has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for 'Omjjara', or momelotinib, as a treatment for myelofibrosis.

Read more
20 Jun 2024 16:01

Industry groups back drugmakers' appeal in Zantac cancer lawsuits

June 20 (Reuters) - A bid by GSK and other drugmakers to stop more than 70,000 lawsuits in Delaware over discontinued heartburn drug Zantac has received the backing of leading U.S. industry groups, including the United States Chamber of Commerce and Pharmaceutical Research and Manufacturers of America.

Read more
11 Jun 2024 14:31

Zantac litigation fears overdone at GSK, says Shore Capital

(Sharecast News) - Volatile moves in GSK's share price are likely to persist in the near term as a result of ongoing Zantac-related litigation, but the long-term investment case is "still appealing", according to Shore Capital, which kept a 'buy' rating on the stock.

Read more
11 Jun 2024 09:32

TOP NEWS: GSK takes first steps to appeal Zantac ruling in Delaware

(Alliance News) - GSK PLC on Tuesday said it has taken the first steps to seek appeal of a ruling by the Delaware Superior Court in regard to its discontinued heartburn drug Zantac.

Read more
11 Jun 2024 09:12

LONDON MARKET OPEN: FTSE 100 up; UK unemployment rises to 4.4%

(Alliance News) - Stock prices in London opened higher on Tuesday, after a difficult day for markets on Monday amid the EU election fallout.

Read more
11 Jun 2024 07:52

LONDON BRIEFING: FTSE 100 called up despite unemployment rise

(Alliance News) - The FTSE 100 in London was called to open higher on Tuesday, after data showed that unemployment in the UK unexpectedly rose.

Read more
11 Jun 2024 07:22

GSK launches appeal to recent Zantac ruling

(Sharecast News) - GSK has started the process of appealing a recent decision by the Delaware Superior Court regarding the ongoing Zantac, or ranitidine, litigation, it announced on Tuesday.

Read more
11 Jun 2024 00:32

GSK asks to appeal Delaware ruling allowing Zantac cases to go forward

June 10 (Reuters) -

Read more
10 Jun 2024 22:49

Latest trial over Zantac cancer claims called off as plaintiff drops case

June 10 (Reuters) - A woman who claimed in a lawsuit that GSK's discontinued heartburn drug Zantac caused her breast cancer dropped her case shortly before it was set to go to trial in Illinois state court on Monday, the company announced.

Read more
10 Jun 2024 19:00

TOP NEWS: GSK welcomes dismissal of Zantac case in Illinois

(Alliance News) - GSK PLC on Monday welcomed the dismissal of a case in the US concerning the heartburn drug, Zantac, which was due to start on Monday.

Read more
10 Jun 2024 12:42

EU to secure 40 million avian flu vaccines for 15 countries - officials

BRUSSELS, June 10 (Reuters) - The EU will sign a contract on Tuesday to secure over 40 million doses of a preventative avian flu vaccine for 15 countries with the first shipments heading to Finland, EU officials said on Monday.

Read more
10 Jun 2024 08:39

GSK gets FDA approval for Arexvy vax in 50-59 year olds at risk of RSV

(Alliance News) - GSK PLC on Monday announced that the US Food & Drug Administration has approved an expanded age indication for its respiratory syncytial virus vaccine.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.